EXEL vs XLV
Exelixis Inc (EXEL) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
XLV does not have a complete income-statement cache yet.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. XLV currently screens at market cap $0.
Not investment advice. Open the EXEL and XLV stock pages for the full models.
Not investment advice.